149 related articles for article (PubMed ID: 8714228)
1. The role of chemotherapy in the treatment of adenocarcinoma of the pancreas.
Fennelly D; Kelsen DP
Hepatogastroenterology; 1996; 43(8):356-62. PubMed ID: 8714228
[TBL] [Abstract][Full Text] [Related]
2. Treatment of advanced adenocarcinomas of the exocrine pancreas and the gallbladder with 5-fluorouracil, high dose levofolinic acid and oral hydroxyurea on a weekly schedule. Results of a multicenter study of the Southern Italy Oncology Group (G.O.I.M.).
Gebbia V; Majello E; Testa A; Pezzella G; Giuseppe S; Giotta F; Riccardi F; Fortunato S; Colucci G; Gebbia N
Cancer; 1996 Sep; 78(6):1300-7. PubMed ID: 8826954
[TBL] [Abstract][Full Text] [Related]
3. [Chemotherapy in adenocarcinomas of the pancreas].
Huguier M
Gastroenterol Clin Biol; 2002 Nov; 26(11):1063; discussion 1063-4. PubMed ID: 12483149
[No Abstract] [Full Text] [Related]
4. The treatment of pancreatic cancer.
Yeo CJ; Cameron JL
Ann Chir Gynaecol; 2000; 89(3):225-33. PubMed ID: 11079793
[No Abstract] [Full Text] [Related]
5. Chemotherapy in advanced pancreatic adenocarcinoma.
Kollmannsberger C; Peters HD; Fink U
Cancer Treat Rev; 1998 Apr; 24(2):133-56. PubMed ID: 9728423
[No Abstract] [Full Text] [Related]
6. [Pancreatic cancer. The relative importance of neoadjuvant therapy].
Beger HG; Poch B; Schwarz M; Gansauge F
Chirurg; 2003 Mar; 74(3):202-7. PubMed ID: 12647076
[TBL] [Abstract][Full Text] [Related]
7. [Treatment of carcinoma of the pancreatic head].
Hopt UT
Zentralbl Chir; 2006 Apr; 131(2):115-20. PubMed ID: 16612777
[TBL] [Abstract][Full Text] [Related]
8. Adenocarcinoma of the head of the pancreas: effects of surgical and nonsurgical therapy on survival--a ten-year experience.
Carr JA; Ajlouni M; Wollner I; Wong D; Velanovich V
Am Surg; 1999 Dec; 65(12):1143-9. PubMed ID: 10597062
[TBL] [Abstract][Full Text] [Related]
9. Adjuvant therapy for adenocarcinoma of the pancreas: analysis of reported trials and recommendations for future progress.
Wolff RA; Varadhachary GR; Evans DB
Ann Surg Oncol; 2008 Oct; 15(10):2773-86. PubMed ID: 18612703
[TBL] [Abstract][Full Text] [Related]
10. Histopathological response to preoperative chemoradiation for resectable pancreatic adenocarcinoma: the French Phase II FFCD 9704-SFRO Trial.
Le Scodan R; Mornex F; Partensky C; Mercier C; Valette PJ; Ychou M; Roy P; Scoazec JY
Am J Clin Oncol; 2008 Dec; 31(6):545-52. PubMed ID: 19060585
[TBL] [Abstract][Full Text] [Related]
11. Gemcitabine and cancer of the pancreas: new preparation. Helpful or not?
Prescrire Int; 1999 Jun; 8(41):74-5. PubMed ID: 10558444
[TBL] [Abstract][Full Text] [Related]
12. An evidence-based approach to the surgical management of resectable pancreatic adenocarcinoma.
Stojadinovic A; Brooks A; Hoos A; Jaques DP; Conlon KC; Brennan MF
J Am Coll Surg; 2003 Jun; 196(6):954-64. PubMed ID: 12788434
[TBL] [Abstract][Full Text] [Related]
13. [Clinical role of interleukin-2 in the surgical treatment of liver metastasis due to colon adenocarcinoma].
Brivio F; Fumagalli L; Fattori L; Nespoli L; Denova M; Sargenti E; Nespoli A
Minerva Chir; 2004 Dec; 59(6):573-82. PubMed ID: 15876991
[TBL] [Abstract][Full Text] [Related]
14. Combined radiofrequency ablation and adjuvant liposomal chemotherapy: effect of chemotherapeutic agent, nanoparticle size, and circulation time.
Ahmed M; Lukyanov AN; Torchilin V; Tournier H; Schneider AN; Goldberg SN
J Vasc Interv Radiol; 2005 Oct; 16(10):1365-71. PubMed ID: 16221908
[TBL] [Abstract][Full Text] [Related]
15. Review of adjuvant radiochemotherapy for resected pancreatic cancer and results from Mayo Clinic for the 5th JUCTS symposium.
Miller RC; Iott MJ; Corsini MM
Int J Radiat Oncol Biol Phys; 2009 Oct; 75(2):364-8. PubMed ID: 19735864
[TBL] [Abstract][Full Text] [Related]
16. Thymidylate synthase protein expression: Association with response to neoadjuvant chemotherapy and resection for locally advanced gastric and gastroesophageal adenocarcinoma.
Alexander HR; Grem JL; Hamilton JM; Pass HI; Hong M; Fraker DL; Steinberg SM; McAtee N; Allegra BC; Johnston PG
Cancer J Sci Am; 1995; 1(1):49-54. PubMed ID: 9166454
[TBL] [Abstract][Full Text] [Related]
17. The case for routine use of adjuvant therapy in pancreatic cancer.
Kennedy EP; Yeo CJ
J Surg Oncol; 2007 Jun; 95(7):597-603. PubMed ID: 17230543
[TBL] [Abstract][Full Text] [Related]
18. Resection of hepatic metastasis after 5-fluorouracil and cofactor for colon cancer.
Costantini CL; Reid TR; Bouvet M
Hepatogastroenterology; 2009; 56(91-92):645-9. PubMed ID: 19621672
[TBL] [Abstract][Full Text] [Related]
19. Oxaliplatin, 5-fluorouracil, and leucovorin as second-line treatment for advanced pancreatic cancer.
Novarino A; Satolli MA; Chiappino I; Giacobino A; Bellone G; Rahimi F; Milanesi E; Bertetto O; Ciuffreda L
Am J Clin Oncol; 2009 Feb; 32(1):44-8. PubMed ID: 19194124
[TBL] [Abstract][Full Text] [Related]
20. New techniques and agents in the adjuvant therapy of pancreatic cancer.
Raraty MG; Magee CJ; Ghaneh P; Neoptolemos JP
Acta Oncol; 2002; 41(7-8):582-95. PubMed ID: 14651201
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
